$EBS
Emergent BioSolutions Inc. Stock $ebs

$ebs Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-Q Financial Statement

#000136764422000119 Filed on August 02, 2022

Income Statement

Concept	2022 Q3	2022 Q2	2022 Q1
Revenue	$240.0M	$242.7M	$307.5M
YoY Change	-27.05%	-38.94%	-10.35%
Cost Of Revenue	$148.6M	$169.8M	$155.9M
YoY Change	-31.68%	-25.46%	57.0%
Gross Profit	$74.00M	$65.60M	$142.0M
YoY Change	-33.63%	-54.54%	-36.15%
Gross Profit Margin	30.83%	27.03%	46.18%
Selling, General & Admin	$80.20M	$81.10M	$84.80M
YoY Change	-2.31%	-11.07%	4.82%
% of Gross Profit	108.38%	123.63%	59.72%
Research & Development	$39.20M	$49.80M	$46.40M
YoY Change	-20.97%	1.84%	-11.62%
% of Gross Profit	52.97%	75.91%	32.68%
Depreciation & Amortization	$20.40M	$28.50M	$30.90M
YoY Change	-37.61%	54.05%	7.67%
% of Gross Profit	27.57%	43.45%	21.76%
Operating Expenses	$119.4M	$130.9M	$131.2M
YoY Change	-9.34%	-6.57%	-1.65%
Operating Profit	-$42.00M	-$72.00M	$6.400M
YoY Change	21.04%	-596.55%	-93.29%
Interest Expense	$8.500M	$7.800M	$8.200M
YoY Change	1.19%	-9.3%	-3.53%
% of Operating Profit			128.13%
Other Income/Expense, Net	-$21.90M	-$10.80M	-$10.20M
YoY Change	102.78%	47.95%	0.0%
Pretax Income	-$63.90M	-$82.80M	-$3.800M
YoY Change	40.44%	-1250.0%	-104.46%
Income Tax	$11.80M	-$26.40M	-$100.0K
% Of Pretax Income
Net Earnings	-$75.70M	-$56.40M	-$3.700M
YoY Change	131.5%	-1326.09%	-105.31%
Net Earnings / Revenue	-31.54%	-23.24%	-1.2%
Basic Earnings Per Share	-$1.52	-$1.13	-$0.07
Diluted Earnings Per Share	-$1.52	-$1.13	-$0.07
COMMON SHARES
Basic Shares Outstanding	49.86M shares	50.00M shares	50.70M shares
Diluted Shares Outstanding	49.90M shares	50.00M shares	50.70M shares

Balance Sheet

Concept	2022 Q3	2022 Q2	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$240.9M	$358.1M	$435.8M
YoY Change	-40.34%	-19.98%	-20.45%
Cash & Equivalents	$240.9M	$358.1M	$435.8M
Short-Term Investments
Other Short-Term Assets	$140.0M	$125.6M	$82.00M
YoY Change	177.23%	372.18%	7354.55%
Inventory	$546.3M	$425.5M	$400.7M
Prepaid Expenses
Receivables	$191.3M	$175.0M	$181.8M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.119B	$1.084B	$1.100B
YoY Change	0.63%	-6.7%	-6.84%
LONG-TERM ASSETS
Property, Plant & Equipment	$806.7M	$798.4M	$807.5M
YoY Change	4.94%	7.38%	16.54%
Goodwill	$224.9M	$224.9M	$224.9M
YoY Change	-15.61%	-15.64%	-15.61%
Intangibles	$722.7M	$576.6M	$590.6M
YoY Change	16.83%	-8.92%	-8.89%
Long-Term Investments
YoY Change
Other Assets	$35.70M	$51.30M	$57.10M
YoY Change	-65.07%	-53.32%	-48.74%
Total Long-Term Assets	$1.790B	$1.651B	$1.680B
YoY Change	1.94%	-5.81%	-2.26%
TOTAL ASSETS
Total Short-Term Assets	$1.119B	$1.084B	$1.100B
Total Long-Term Assets	$1.790B	$1.651B	$1.680B
Total Assets	$2.909B	$2.735B	$2.780B
YoY Change	1.43%	-6.17%	-4.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$103.8M	$106.2M	$107.3M
YoY Change	-23.22%	-30.04%	-24.54%
Accrued Expenses	$35.90M	$40.30M	$29.30M
YoY Change	-16.32%	19.23%	17.2%
Deferred Revenue	$24.80M	$18.50M	$10.00M
YoY Change	-32.61%	-66.06%	-83.42%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$21.20M	$31.60M	$31.60M
YoY Change	-32.91%	9.72%	21.54%
Total Short-Term Liabilities	$268.4M	$276.7M	$249.2M
YoY Change	-26.55%	-26.76%	-32.69%
LONG-TERM LIABILITIES
Long-Term Debt	$1.032B	$793.6M	$801.5M
YoY Change	26.28%	-3.83%	-3.79%
Other Long-Term Liabilities	$44.90M	$58.50M	$49.30M
YoY Change	-23.51%	-4.72%	-21.62%
Total Long-Term Liabilities	$1.077B	$852.1M	$850.8M
YoY Change	22.95%	-3.89%	-5.04%
TOTAL LIABILITIES
Total Short-Term Liabilities	$268.4M	$276.7M	$249.2M
Total Long-Term Liabilities	$1.077B	$852.1M	$850.8M
Total Liabilities	$1.459B	$1.222B	$1.205B
YoY Change	8.51%	-10.89%	-12.5%
SHAREHOLDERS EQUITY
Retained Earnings	$822.0M	$897.7M	$954.1M
YoY Change	6.96%	12.04%	19.77%
Common Stock	$100.0K	$100.0K	$100.0K
YoY Change	0.0%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$227.7M	$227.7M	$204.4M
YoY Change	475.0%	475.0%	416.16%
Treasury Stock Shares	5.600M shares	5.600M shares	4.900M shares
Shareholders Equity	$1.449B	$1.513B	$1.575B
YoY Change
Total Liabilities & Shareholders Equity	$2.909B	$2.735B	$2.780B
YoY Change	1.43%	-6.17%	-4.13%

Cashflow Statement

Concept	2022 Q3	2022 Q2	2022 Q1
OPERATING ACTIVITIES
Net Income	-$75.70M	-$56.40M	-$3.700M
YoY Change	131.5%	-1326.09%	-105.31%
Depreciation, Depletion And Amortization	$20.40M	$28.50M	$30.90M
YoY Change	-37.61%	54.05%	7.67%
Cash From Operating Activities	-$74.00M	-$15.60M	-$37.30M
YoY Change	-543.11%	-47.47%	-831.37%
INVESTING ACTIVITIES
Capital Expenditures	-$271.6M	-$32.10M	$32.20M
YoY Change	392.03%	-52.09%	-42.6%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$271.6M	-$32.10M	-$32.20M
YoY Change	392.03%	-52.09%	-42.6%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$57.50M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	229.3M	-30.70M	-$70.50M
YoY Change	-4686.0%	707.89%	217.57%
NET CHANGE
Cash From Operating Activities	-74.00M	-15.60M	-$37.30M
Cash From Investing Activities	-271.6M	-32.10M	-$32.20M
Cash From Financing Activities	229.3M	-30.70M	-$70.50M
Net Change In Cash	-116.3M	-78.40M	-$140.3M
YoY Change	167.36%	-21.99%	90.88%
FREE CASH FLOW
Cash From Operating Activities	-$74.00M	-$15.60M	-$37.30M
Capital Expenditures	-$271.6M	-$32.10M	$32.20M
Free Cash Flow	$197.6M	$16.50M	-$69.50M
YoY Change	174.83%	-55.76%	36.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001367644
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y4M24D
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20879
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherAssetsNoncurrent
CY2022Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2021Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilitiesNoncurrent
CY2020Q3	ebs	Debt Instrument Covenant Net Leverage Ratio Adjustment Period DebtInstrumentCovenantNetLeverageRatioAdjustmentPeriod	P12M
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-33137
	dei	Entity Registrant Name EntityRegistrantName	EMERGENT BIOSOLUTIONS INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	14-1902018
	dei	Entity Address Address Line1 EntityAddressAddressLine1	400 Professional Drive Suite 400
	dei	Entity Address City Or Town EntityAddressCityOrTown	Gaithersburg,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	City Area Code CityAreaCode	240
	dei	Local Phone Number LocalPhoneNumber	631-3200
	dei	Security12b Title Security12bTitle	Common Stock, Par Value $0.001 per share
	dei	Trading Symbol TradingSymbol	EBS
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49861509	shares
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	358100000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	576100000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	96200000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	175000000.0	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	274700000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	425500000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	350800000	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	125400000	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	70300000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	1084200000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1272100000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	798400000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	800100000	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	576600000	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	604600000	usd
CY2022Q2	us-gaap	Goodwill Goodwill	224900000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	224900000	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	51300000	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	57300000	usd
CY2022Q2	us-gaap	Assets Assets	2735400000	usd
CY2021Q4	us-gaap	Assets Assets	2959000000	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	106200000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	128900000	usd
CY2022Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40300000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	51700000	usd
CY2022Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	74400000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	88700000	usd
CY2022Q2	us-gaap	Notes Payable Current NotesPayableCurrent	31600000	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	31600000	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	24200000	usd
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	72900000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	276700000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	373800000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	793600000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	809400000	usd
CY2022Q2	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	93400000	usd
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	94900000	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	58500000	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	61900000	usd
CY2022Q2	us-gaap	Liabilities Liabilities	1222200000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	1340000000	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000.0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000.0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000.0	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000.0	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55500000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	55100000	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49900000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51300000	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	100000	usd
CY2022Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	5600000	shares
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	3800000	shares
CY2022Q2	us-gaap	Treasury Stock Value TreasuryStockValue	227700000	usd
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	152200000	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	849200000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	829400000	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-6100000	usd
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-16100000	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	897700000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	957800000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1513200000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1619000000	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2735400000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2959000000	usd
CY2022Q2	us-gaap	Revenues Revenues	242700000	usd
CY2021Q2	us-gaap	Revenues Revenues	397500000	usd
	us-gaap	Revenues Revenues	550200000	usd
	us-gaap	Revenues Revenues	740500000	usd
CY2022Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	49800000	usd
CY2021Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	48900000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	101400000	usd
CY2022Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	81100000	usd
CY2021Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	91200000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	165900000	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	172100000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000000.0	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28000000.0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000000.0	usd
CY2022Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	314700000	usd
CY2021Q2	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	383000000.0	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	615800000	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	630600000	usd
CY2022Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-72000000.0	usd
CY2021Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	14500000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-65600000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	109900000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	7800000	usd
CY2021Q2	us-gaap	Interest Expense InterestExpense	8600000	usd
	us-gaap	Interest Expense InterestExpense	16000000.0	usd
	us-gaap	Interest Expense InterestExpense	17100000	usd
CY2022Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3000000.0	usd
CY2021Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1300000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5000000.0	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-400000	usd
CY2022Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10800000	usd
CY2021Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7300000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-21000000.0	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17500000	usd
CY2022Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-82800000	usd
CY2021Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	7200000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-86600000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	92400000	usd
CY2022Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26400000	usd
CY2021Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2600000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-26500000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18100000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56400000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-60100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74300000	usd
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.40
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000.0	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53500000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000.0	shares
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54000000.0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54300000	shares
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56400000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-60100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74300000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	400000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	500000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	900000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1700000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	2800000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	1500000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	9100000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	4600000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3200000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000000.0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2900000	usd
CY2022Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-53200000	usd
CY2021Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	6600000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50100000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	77200000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-60100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74300000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	22200000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	21900000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	75400000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	61900000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1800000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1700000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000000.0	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2000000.0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2600000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3200000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2200000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-2000000.0	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-97700000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34700000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	75500000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	79700000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	19400000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2400000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-7600000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	8000000.0	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-82800000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-55400000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-14100000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-21400000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2700000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	400000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-52900000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-24600000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	64300000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	123100000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-64300000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-123100000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	81900000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	16900000	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	11300000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	10600000	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3000000.0	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	10000000.0	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5400000	usd
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13000000.0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	1100000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-101200000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-26000000.0	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	400000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	545100000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-100000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-218000000.0	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-173800000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	576300000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	621500000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	358300000	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	447700000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14800000	usd
	us-gaap	Interest Paid Net InterestPaidNet	15500000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	20000000.0	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	50300000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7300000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	31700000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	358100000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	576100000	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2021Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	200000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	358300000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	576300000	usd
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1619000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	19800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-60100000	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	75500000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000000.0	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1513200000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	1575300000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14400000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56400000	usd
CY2022Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	23300000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3200000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	1513200000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	1447000000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	19500000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74300000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2900000	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1543700000	usd
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	1522800000	usd
CY2021Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	14300000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4600000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	1543700000	usd
	ebs	Number Of Categories Of Public Health Threats NumberOfCategoriesOfPublicHealthThreats	5	category
	ebs	Number Of Revenue Generating Products NumberOfRevenueGeneratingProducts	11	product
	ebs	Number Of Product Candidates NumberOfProductCandidates	1	productcandidate
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	319100000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	798400000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1119200000	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	357700000	usd
CY2022Q2	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	264000000.0	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	217500000	usd
CY2022Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	108400000	usd
CY2021Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	95800000	usd
CY2022Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53100000	usd
CY2021Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	37500000	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	425500000	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	350800000	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1156100000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	800100000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1400000	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1500000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2800000	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2800000	usd
CY2022Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	usd
CY2021Q2	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	600000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	700000	usd
CY2022Q2	us-gaap	Lease Cost LeaseCost	1700000	usd
CY2021Q2	us-gaap	Lease Cost LeaseCost	1800000	usd
	us-gaap	Lease Cost LeaseCost	3400000	usd
	us-gaap	Lease Cost LeaseCost	3500000	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25500000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	28300000	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5900000	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5800000	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	20900000	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	24200000	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	26800000	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	30000000.0	usd
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y8M12D
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.041
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	803500000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	226900000	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	576600000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	803500000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	198900000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	604600000	usd
CY2022Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14000000.0	usd
CY2021Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	15100000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	28000000.0	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	30000000.0	usd
CY2021Q4	us-gaap	Goodwill Goodwill	224900000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	0	usd
CY2022Q2	us-gaap	Goodwill Goodwill	224900000	usd
CY2022Q2	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	41700000	usd
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	41700000	usd
CY2022Q2	us-gaap	Derivative Assets DerivativeAssets	6300000	usd
CY2021Q4	us-gaap	Derivative Assets DerivativeAssets	0	usd
CY2022Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	181600000	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	352400000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	8100000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	37200000	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	6100000	usd
CY2022Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	8100000	usd
CY2021Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	43300000	usd
CY2021Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	37200000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1800000	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	30900000	usd
CY2022Q2	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	8100000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	3600000	usd
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	32700000	usd
CY2022Q2	us-gaap	Long Term Debt LongTermDebt	832700000	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	849600000	usd
CY2022Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	31600000	usd
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	31600000	usd
CY2022Q2	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	7500000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Noncurrent Net DeferredFinanceCostsNoncurrentNet	8500000	usd
CY2022Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	793600000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	809400000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Current Net DeferredFinanceCostsCurrentNet	2000000	usd
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1600000	usd
CY2020Q3	ebs	Debt Instrument Covenant Net Leverage Ratio Rolling Period DebtInstrumentCovenantNetLeverageRatioRollingPeriod	P12M
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2022Q2	us-gaap	Revenues Revenues	242700000	usd
CY2021Q2	us-gaap	Revenues Revenues	397500000	usd
	us-gaap	Revenues Revenues	550200000	usd
	us-gaap	Revenues Revenues	740500000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	545100000	usd
CY2022Q2	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P24M
CY2022Q2	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	26300000	usd
CY2021Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	21500000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	16400000	usd
	ebs	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	17900000	usd
	ebs	Contract With Customer Liability Deductions ContractWithCustomerLiabilityDeductions	10000000.0	usd
CY2022Q2	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24300000	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	18500000	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11700000	usd
CY2022Q2	us-gaap	Billed Contract Receivables BilledContractReceivables	119900000	usd
CY2021Q4	us-gaap	Billed Contract Receivables BilledContractReceivables	224900000	usd
CY2022Q2	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	55100000	usd
CY2021Q4	us-gaap	Unbilled Contracts Receivable UnbilledContractsReceivable	49800000	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	175000000.0	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	274700000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	900000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	3200000	usd
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.26
CY2022Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	200000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	600000	usd
CY2021Q2	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1100000	usd
	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-5500000	usd
CY2021Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54000000.0	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50300000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	54300000	shares
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-56400000	usd
CY2021Q2	us-gaap	Net Income Loss NetIncomeLoss	4600000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-60100000	usd
	us-gaap	Net Income Loss NetIncomeLoss	74300000	usd
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50000000.0	shares
CY2021Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53600000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	50300000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	53500000	shares
CY2022Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	400000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	800000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000.0	shares
CY2021Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.19
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.40
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
CY2021Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.19
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.37
CY2022Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1800000	shares
CY2021Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3000000.0	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	500000	shares
CY2021Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	250000000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2900000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12300000	usd
CY2021Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11400000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	22200000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	21900000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	7700000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-2300000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000000.0	usd
CY2022Q2	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	2300000	usd
CY2022Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-900000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3200000	usd
	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-100000	usd
	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-3000000.0	usd
CY2021Q2	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	400000	usd
CY2021Q2	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	-1600000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	5100000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	1900000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	3200000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1700000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-300000	usd
CY2021Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2000000.0	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	14400000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	4400000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	10000000.0	usd
	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	1900000	usd
	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-1000000.0	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	2900000	usd
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2022Q2	us-gaap	Revenues Revenues	242700000	usd
CY2021Q2	us-gaap	Revenues Revenues	397500000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	65600000	usd
CY2021Q2	us-gaap	Gross Profit GrossProfit	144300000	usd
CY2022Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1300000	usd
CY2021Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	600000	usd
CY2022Q2	ebs	Adjusted Gross Margin AdjustedGrossMargin	66900000	usd
CY2021Q2	ebs	Adjusted Gross Margin AdjustedGrossMargin	144900000	usd
	us-gaap	Revenues Revenues	550200000	usd
	us-gaap	Revenues Revenues	740500000	usd
	us-gaap	Gross Profit GrossProfit	207600000	usd
	us-gaap	Gross Profit GrossProfit	366700000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1800000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1700000	usd
	ebs	Adjusted Gross Margin AdjustedGrossMargin	209400000	usd
	ebs	Adjusted Gross Margin AdjustedGrossMargin	368400000	usd
CY2022Q2	us-gaap	Depreciation Depreciation	28500000	usd
CY2021Q2	us-gaap	Depreciation Depreciation	18500000	usd
	us-gaap	Depreciation Depreciation	45100000	usd
	us-gaap	Depreciation Depreciation	32100000	usd

Files In Submission

Name	View Source	Status
0001367644-22-000119-index-headers.html	Edgar Link	pending
0001367644-22-000119-index.html	Edgar Link	pending
0001367644-22-000119.txt	Edgar Link	pending
0001367644-22-000119-xbrl.zip	Edgar Link	pending
a200-2017x92634xmod28exe.htm	Edgar Link	pending
a200-2017x92634xmod28exe001.jpg	Edgar Link	pending
a200-2017x92634xmod28exe002.jpg	Edgar Link	pending
a200-2017x92634xmod28exe003.jpg	Edgar Link	pending
a200-2017x92634xmod28exe004.jpg	Edgar Link	pending
a200-2017x92634xmod28exe005.jpg	Edgar Link	pending
a200-2017x92634xmod29exe.htm	Edgar Link	pending
a200-2017x92634xmod29exe001.jpg	Edgar Link	pending
a200-2017x92634xmod29exe002.jpg	Edgar Link	pending
a200-2017x92634xmod29exe003.jpg	Edgar Link	pending
a200-2017x92634xmod29exe004.jpg	Edgar Link	pending
a311-kramercert63022.htm	Edgar Link	pending
a312-lindhalcert63022.htm	Edgar Link	pending
a321-kramercert63022.htm	Edgar Link	pending
a322-lindhalcert63022.htm	Edgar Link	pending
ebs-20220630.htm	Edgar Link	pending
ebs-20220630.xsd	Edgar Link	pending
ebs-20220630_cal.xml	Edgar Link	unprocessable
ebs-20220630_def.xml	Edgar Link	unprocessable
ebs-20220630_g1.jpg	Edgar Link	pending
ebs-20220630_g2.jpg	Edgar Link	pending
ebs-20220630_g3.jpg	Edgar Link	pending
ebs-20220630_g4.jpg	Edgar Link	pending
ebs-20220630_g5.jpg	Edgar Link	pending
ebs-20220630_g6.jpg	Edgar Link	pending
ebs-20220630_g7.jpg	Edgar Link	pending
ebs-20220630_g8.jpg	Edgar Link	pending
ebs-20220630_g9.jpg	Edgar Link	pending
ebs-20220630_htm.xml	Edgar Link	completed
ebs-20220630_lab.xml	Edgar Link	unprocessable
ebs-20220630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EBS
Emergent BioSolutions Inc. Stock $ebs

2022 Q3 Form 10-Q Financial Statement

#000136764422000119 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EBS Emergent BioSolutions Inc. Stock $ebs

2022 Q3 Form 10-Q Financial Statement

#000136764422000119 Filed on August 02, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EBS
Emergent BioSolutions Inc. Stock $ebs